Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591Anna Rominski, Anna Roditscheff, Petra Selchow, et al.
Frontiers in Microbiology|November 23, 2017
Lipoprotein Glycosylation by Protein-O-Mannosyltransferase (MAB_1122c) Contributes to Low Cell Envelope Permeability and Antibiotic Resistance of Mycobacterium abscessusKatja Becker, Klara Haldimann, Petra Selchow, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2017
Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genesAnna Rominski, Petra Selchow, Katja Becker, et al.
Microbiology (Reading, England)|October 4, 2008
LspA inactivation in Mycobacterium tuberculosis results in attenuation without affecting phagosome maturation arrestSilvana K Rampini, Petra Selchow, Christine Keller, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2020
Rifabutin Is Inactivated by Mycobacterium abscessus ArrDaniel Schäfle, Petra Selchow, Barbara Borer, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 16, 2019
Identification of novel scaffolds targeting Mycobacterium tuberculosisMichael Dal Molin, Petra Selchow, Daniel Schäfle, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2011
Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosisThomas Grau, Petra Selchow, Marcel Tigges, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2014
Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitorMattia Mori, Francesca Moraca, Davide Deodato, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2010
Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targetingNicole Joller, Stefan S Weber, Andreas J Müller, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2021
Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessusPetra Selchow, Diane J Ordway, Deepshikha Verma, et al.
Pageof 2